Castle Biosciences Inc.

NASDAQ: CSTL · Real-Time Price · USD
20.09
0.27 (1.36%)
At close: Aug 15, 2025, 3:59 PM
19.70
-1.94%
After-hours: Aug 15, 2025, 06:46 PM EDT

Castle Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
4.52M -25.85M 9.59M 2.27M 8.92M -2.53M -2.58M -6.91M -18.78M -29.2M -20.62M -20.25M -1.65M -24.62M -6.43M -11.79M -8.79M -4.28M
Depreciation & Amortization
3.41M 29.76M 5.77M 3.54M 3.35M 3.34M 3.22M 3.17M 3.04M 2.89M 2.84M 2.92M 2.63M 2.15M 1.45M 1.09M 634K 233K
Stock-Based Compensation
11.21M 11.18M 11.44M 13.03M 13.18M 12.68M 11.8M 13.04M 12.85M 13.53M 9.92M 9.2M 8.78M 8.42M 6.85M 5.21M 4.77M 4.91M
Other Working Capital
5.04M -17.07M 4.88M 5.74M 6.87M -14.41M 7.98M 3.02M 6.17M -10.62M 5.7M 1.73M 7.09M -7.21M 3.03M -766K 961K -2.84M
Other Non-Cash Items
-2.17M 20K -2.11M -17.63M 23.01M 22.22M 4.2M -1.53M -1.07M -1.02M -1.51M -188K -20.37M 2.57M 99K -168K 36K 33K
Deferred Income Tax
-4.67M -770K -2.31M 5.25M -1.54M n/a -236K 32K 16K 13K -38K n/a -1.96M 123K -8.74M n/a n/a n/a
Change in Working Capital
8.51M -20.38M 1.98M 16.88M 1.91M -18.8M 7.67M -2.8M 153K -11.65M 3.4M 3.09M 3.57M -10.07M 3.98M -473K -3.08M -4.53M
Operating Cash Flow
20.82M -6.04M 24.36M 23.34M 24M -6.83M 24.08M 5.01M -3.79M -25.44M -6M -5.22M -9M -21.43M -2.78M -6.13M -6.44M -3.63M
Capital Expenditures
-9.26M -4.74M -7.57M -6.38M -5.23M -9.15M -3.79M -2.46M -4.04M -3.34M -1.79M -2.04M -1.41M -402K -893K -927K -913K -750K
Cash Acquisitions
-18.73M n/a n/a n/a 2K 5K 3K 2K 3K 5K 27.51M -305K -26.66M n/a -63.18M -33.18M 2K n/a
Purchase of Investments
-44.4M -48.43M -47.32M -45.22M -52.44M -60.75M -52.38M -50.26M -56.35M -30.08M -2.88M -131.81M n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
44M 36.3M 60.65M 36.8M 36.25M 50.2M 48.5M 43M 45M 50M n/a 131.81M n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
12K -5.56M 7K 4K -16.19M -10.55M -3.88M -7.25M -11.35M 19.92M -27.33M -131.81M 555K n/a 33.19M 4K -33.18M n/a
Investing Cash Flow
-28.38M -22.43M 5.77M -14.79M -21.42M -19.7M -7.67M -9.71M -15.39M 16.58M -4.48M -134.15M -27.51M -402K -30.89M -923K -34.09M -750K
Debt Repayment
-57K -26K -26K -24K -11K 9.96M -36K -36K -35K -35K -34K -33K -31K -24K n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a 1.09M -615K -474K -4.01M -271K -534K -314K -1.55M -46K -32K -56K -781K n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
139K -1.54M -5.73M -709K 53K 680K -3.26M 81K 261K 763K -716K 421K 692K 1.24M 907K 1.89M 1.89M 1.51M
Financial Cash Flow
101K -1.55M -5.38M 838K 42K 10.64M -3.3M 45K 226K 728K -750K 388K 661K 1.22M 126K 1.89M 1.89M 1.51M
Net Cash Flow
-7.46M -30.02M 24.75M 9.39M 2.62M -15.89M 7.62M -4.65M -18.95M -8.13M -11.23M -138.99M -35.85M -20.62M -33.54M -5.16M -38.64M -2.87M
Free Cash Flow
11.56M -10.78M 16.8M 16.96M 18.77M -15.99M 20.29M 2.56M -7.82M -28.78M -7.79M -7.26M -10.41M -21.83M -3.67M -7.06M -7.35M -4.38M